VNRX - VolitionRX Limited Common Stock -  [ ]

Ticker Details
VolitionRX Limited Common Stock
VolitionRX Ltd is a clinical-stage life sciences company. The company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
IPO Date: April 1, 2012
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $27.11M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.09 | 3.39%
Avg Daily Range (30 D): $0.01 | 4.42%
Avg Daily Range (90 D): $0.01 | 4.37%
Institutional Daily Volume
Avg Daily Volume: .19M
Avg Daily Volume (30 D): 1.81M
Avg Daily Volume (90 D): 2.04M
Trade Size
Avg Trade Size (Sh.): 328
Avg Trade Size (Sh.) (30 D): 603
Avg Trade Size (Sh.) (90 D): 646
Institutional Trades
Total Institutional Trades: 12
Avg Institutional Trade: $2.06M
Avg Institutional Trade (30 D): $.68M
Avg Institutional Trade (90 D): $.68M
Avg Institutional Trade Volume: .63M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.26M
Avg Closing Trade (30 D): $.68M
Avg Closing Trade (90 D): $.68M
Avg Closing Volume: 984.71K
 
News
Jan 3, 2024 @ 12:59 PM
Why Trinity Place Holdings Shares Are Trading High...
Source: Avi Kapoor
Nov 27, 2023 @ 11:26 AM
IO Biotech And 2 Other Stocks Under $2 Insiders Ar...
Source: Lisa Levin
Nov 20, 2023 @ 1:45 PM
Ondas Holdings And 2 Other Stocks Under $1 Insider...
Source: Lisa Levin
Oct 6, 2023 @ 12:26 PM
Top 4 Health Care Stocks That Are Preparing To Pum...
Source: Lisa Levin
Sep 22, 2023 @ 6:22 PM
Why Flux Power Shares Are Trading Lower By 15%? He...
Source: Lisa Levin
Financials
  TTM Q3 2025 Q2 2025
Basic EPS
Diluted EPS $-.23 $-.05 $-.06
Revenue $1.47M $.63M $.41M
Gross Profit
Net Income / Loss $-23.06M $-5.41M $-6.31M
Operating Income / Loss $-22.7M $-5.1M $-6.3M
Cost of Revenue
Net Cash Flow $-5.21M $-2.06M $-.34M
PE Ratio